Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: A gender-specific phenotype

Cardiovascular Research

Volumn 57, Issue 2, 2003, Pages 395-404

  Du, Xiao Jun ^a   Samuel, Chrishan S ^b   Gao, Xiao Ming ^a   Zhao, Ling ^b,c   Parry, Laura J ^b   Tregear, Geoffrey W ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Fibrosis; Gender; Gene expression; Hormones; Ventricular function

Indexed keywords

COLLAGEN; PEPTIDE HORMONE; PROCOLLAGEN; RELAXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; FLOW RATE; GENE EXPRESSION; GENE TARGETING; GENETIC VARIABILITY; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; HETEROZYGOSITY; HISTOLOGY; KNOCKOUT MOUSE; MALE; MORPHOLOGICAL TRAIT; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TRANSTHORACIC ECHOCARDIOGRAPHY; WILD TYPE;

ANIMALS; COLLAGEN; FEMALE; GENE EXPRESSION; HEART ATRIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; PHENOTYPE; RELAXIN; SEX CHARACTERISTICS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 12244257489     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00663-6     Document Type: Article

References (40)

1. Sherwood O.D. 2nd ed Relaxin. The physiology of reproduction. vol. 1:1994;861-1009 Raven Press, New York.
2. Samuel C.S., Butkus A., Coghlan J.P., Bateman J.F. The effect of relaxin on collagen metabolism in the non-pregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity. Endocrinology. 137:1996;3884-3890.
3. Bryant-Greenwood G.D., Schwabe C. Human relaxins: chemistry and biology. Endocrinol Rev. 15:1994;5-26.
4. Samuel C.S., Coghlan J.P., Bateman J.F. Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat pubic symphysis. J Endocrinol. 159:1998;117-125.
5. Goldsmith L.T., Weiss G., Palejwala S. Mechanism of relaxin action in human cervix. Tregear G.W., Ivell R., Bathgate R.A.D., Wade J.D. Relaxin 2000. 2001;285-289 Kluwer Academic Publishers, Dordrecht.
6. Bathgate R.A., Samuel C.S., Burazin T.C., et al. Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene: novel members of the relaxin peptide family. J Biol Chem. 277:2002;1148-1157.
7. Evans B.A., John M., Fowler K.J., et al. The mouse relaxin gene: nucleotide sequence and expression. J Mol Endocrinol. 10:1993;15-23.
8. Zhao L., Roche P.J., Gunnersen J.M., et al. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology. 140:1999;445-453.
9. Zhao L., Samuel C.S., Tregear G.W., Beck F., Wintour E.M. Collagen studies in late pregnant relaxin null mice. Biol Reprod. 63:2000;697-703.
10. Samuel C.S., Amento E.P. Relaxin knockout mice demonstrate delayed growth and have underdeveloped male reproductive tracts. Tregear G.W., Ivell R., Bathgate R.A.D., Wade J.D. Relaxin 2000. 2001;221-223 Kluwer Academic Publishers, Dordrecht.
11. Tan Y.Y., Wade J.D., Tregear G.W., Summers R.J. Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment. Br J Pharmacol. 127:1999;91-98.
12. Osheroff P.L., Ho W.H. Expression of relaxin mRNA and relaxin receptors in postnatal and adult rat brains and hearts. Localization and developmental patterns. J Biol Chem. 268:1993;15193-15199.
13. Thomas G.R., Vandlen R. The purely chronotropic effects of relaxin in the rat isolated heart. J Pharm Pharmacol. 45:1993;927-928.
14. Kakouris H., Eddie L.W., Summers R.J. Cardiac effects of relaxin in rats. Lancet. 339:1992;1076-1078.
15. Parry L.J., Poterski R.S., Summerlee A.J.S., Jones S.A. Mechanism of the haemotensive action of porcine relaxin in anaesthetized rats. J Neuroendocrinol. 2:1990;53-58.
16. Toth M., Taskinen P., Ruskoaho H. Relaxin stimulates atrial natriuretic peptide secretion in perfused rat heart. J Endocrinol. 150:1996;487-495.
17. Bani-Sacchi T., Bigazzi M., Bani D., Mannaioni P.F., Masini E. Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol. 116:1995;1589-1594.
18. Taylor M.J., Clark C.L. Evidence for a novel source of relaxin: atrial cardiocytes. J Endocrinol. 143:1994;R5-R8.
19. Dschietzig T., Richter C., Bartsch C., et al. The pregnancy hormone relaxin is a player in human heart failure. FASEB J. 15:2001;2187-2195.
20. Gao X.M., Dart A.M., Dewar E., Jennings G., Du X.J. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res. 45:2000;330-338.
21. Nishmura R.A., Abel M.D., Hatle L.K., Tajik A.J. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Mayo Clin Proc. 64:1989;181-204.
22. Knollmann B.C., Blatt S.A., Horton K., et al. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation liked to familial hypertrophic cardiomyopathy. J Biol Chem. 276:2001;10039-10048.
23. 2-Adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation. 101:2000;71-77.
24. Young M., Fullerton M., Dilley R., Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 93:1994;2578-2583.
25. Siebel A.L., Gehring H.M., Nave C.D., Bathgate R.A.D., Borchers C.E., Parry L.J. The upregulation of mesotocin receptors in the tammar wallaby myometrium is pregnancy-specific and independent of estrogen. Biol Reprod. 66:2002;1237-1243.
26. Fisher C., MacLean M., Morecroft I., et al. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation. 106:2002;292-295.
27. Danielson L.A., Kercher L.J., Conrad K.P. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol. 279:2000;R1298-R1304.
28. Geddes B.J., Parry L.J., Summerlee A.J.S. Brain angiotensin-II partially mediates the effects of relaxin on vasopressin and oxytocin release in anesthetized rats. Endocrinology. 134:1994;1188-1192.
29. Failli P., Nistri S., Quattrone S., et al. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J. 16:2002;252-254.
30. Samuel CS, Zhao C, Bathgate RAD et al., Relaxin deficient mice are associated with an age-related progression of pulmonary fibrosis. FASEB J (in press).
31. Unemori E.N., Amento E.P. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem. 265:1990;10681-10685.
32. Unemori E.N., Pickford L.B., Salles A.L., et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest. 98:1996;2739-2745.
33. Lenhart J.A., Ryan P.L., Ohleth K.M., Palmer S.S., Bagnell C.A. Relaxin increases secretion of matrix-metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodelling in the pig. Endocrinology. 142:2001;3941-3949.
34. Williams E.J., Benyon R.C., Trim N., et al. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut. 49:2001;577-583.
35. Garber S.L., Mirochnik Y., Brecklin C.S., et al. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int. 59:2001;876-882.
36. Bani D., Masini E., Bello M.G., Bigazzi M., Sacchi T.B. Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am J Pathol. 152:1998;1367-1376.
37. Kadokami T., McTiernan C.F., Kubota T., Frye C.S., Feldman A.M. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest. 106:2000;589-597.
38. 2-adrenoceptors in the heart. J Mol Cell Cardiol. 33:2001;A37. (abstract).
39. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res. 83:1998;1215-1223.
40. Geisterfer-Lowrance A.A., Christe M., Conner D.A., et al. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:1996;731-734.